Bevacizumab for non‐small‐cell lung cancer: A nested case control study of risk factors for hemoptysis

Potentially life‐threatening, serious hemoptysis is an adverse event associated with bevacizumab in non‐squamous non‐small‐cell lung cancer (NSCLC) trials. Suggested risk factors include central tumor location and cavitation; however, the profile of hemoptysis occurrence in clinical practice is stil...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Koichi, Endo, Masahiro, Kusumoto, Masahiko, Yamamoto, Nobuyuki, Ohe, Yuichiro, Shimizu, Ayaka, Fukuoka, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198952/
https://www.ncbi.nlm.nih.gov/pubmed/27714941
http://dx.doi.org/10.1111/cas.13096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198952/
https://www.ncbi.nlm.nih.gov/pubmed/27714941
http://dx.doi.org/10.1111/cas.13096

Ejemplares similares